Probing Cellular Processes Using Engineered Nanoparticles

Peptide nanostructures-based delivery of DNA nanomaterial therapeutics for regulating gene expression

Self-assembled branched DNA (bDNA) nanomaterials have exhibited their functionality in various biomedical and diagnostic applications. However, the anionic cellular membrane has restricted the movement of bDNA nanostructures. Recently, amphiphilic peptides have been investigated as cationic delivery agents for nucleic acids. Herein, we demonstrate a strategy for delivering functional bDNA nanomaterials into mammalian cells using self-assembled linear peptides. In this study, antisense oligonucleotides of vascular endothelial growth factor (VEGF) were inserted in the overhangs of bDNAs. Novel linear peptides have been synthesized and the peptide-bound bDNA complex formation was examined using various biophysical experiments. Interestingly, the W4R4-bound bDNAs were found to be exceptionally stable against DNase I compared to other complexes. The delivery of fluorescent-labeled bDNAs into the mammalian cells confirmed the potential of peptide transporters. Furthermore, the functional efficacy of the peptide-bound bDNAs has been examined through RT-PCR and western blot analysis. The observed results revealed that W4R4 peptides exhibited excellent internalization of antisense bDNAs and significantly suppressed (3- to 4-fold) the transcripts and translated product of VEGF compared to the control. In summary, the results highlight the potential use of peptide-based nanocarrier for delivering bDNA nanostructures to regulate the gene expression in cell lines.

Transformation of zinc oxide nanoparticles in the presence of aluminum oxide with pre-sorbed phosphorus ligands

Naturally occurring oxides could react with zinc oxide (ZnO) nanoparticles (NPs) and then change its transformation and toxicity to ecological receptors. The reaction may be affected by a variety of environmental factors, yet the relevant processes and mechanisms are limitedly investigated. Natural prevalent ligands, as an important factor, can sorb on natural oxide minerals and change its surface property, finally affecting ZnO NP transformation. This study investigated the interactions of ZnO NPs with phosphorus ligands (i.e., phytate and orthophosphate) pre-sorbed γ-alumina (γ-Al₂O₃) via batch experiments and multi-technique analyses. A limited amount of aqueous Zn²⁺ is observed when the concentration of ZnO NPs is relatively low (<64.8 mg L^-1) in the presence of phytate pre-sorbed γ-Al₂O₃. Solid Zn(II) species includes binary/ternary surface Zn(II) complexes on γ-Al₂O₃ with minor amounts of zinc phytate precipitates. As the concentration of ZnO NPs increases, surface Zn(II) complexes gradually transform into zinc phytate and Zn-Al layered double hydroxide (Zn-Al LDH) precipitates. The quantitative analysis indicates that, as the concentration of ZnO NPs increases from 32.4 to 388.8 mg L^-1, the proportion of Zn(II) species as binary/ternary surface complexes decreases from 81.9 to 30.2%; and the proportion as zinc phytate and Zn-Al LDH increases from 17.9 to 27.6% and 0 to 43.8%, respectively. The pre-sorption of orthophosphate can also inhibit ZnO NP transformation into Zn-Al LDH precipitates on γ-Al₂O₃. This study suggests that natural ligands pre-existed on natural oxide minerals could greatly influence the solubility, stability, transformation, and fate of easily dissoluble metal oxides (e.g., ZnO) in the environments.

Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors

Cancer as a disease possess quite complicated pathophysiological implications and is among the prominent causes of morbidity and mortality on global scales. Anti-cancer chemotherapy, surgery, and radiation therapy are some of the present-day conventional treatment options. However, these therapeutic paradigms own several retreats, including lack of specificity, non-targeted toxicological implications, inefficient drug delivery to targeted cells, and emergence of cancer resistance, ultimately causing ineffective cancer management. Owing to the advanced and better biophysical characteristic features and potentiality for the tailoring and customizations and in several fashions, nanotechnology can entirely transubstantiate the cancer identification and its managements. Additionally, nanotechnology also renders several answers to present-day mainstream limitations springing-up in anti-cancer therapeutics. Nanocarriers, owing to their outstanding physicochemical features including but not limited to their particle size, surface morphological features viz. shape etc., have been employed in nanomedicinal platforms for targeting various transcription factors leading to worthy pharmacological outcomes. This transcription targeting activates the wide array of cellular and molecular events like antioxidant enzyme-induction, apoptotic cell death, cell-cycle arrest etc. These outcomes are obtained after the activation or inactivation of several transcription factors and cellular pathways. Further, nanoformulations have been precisely calibrated and functionalized with peculiar targeting groups for improving their efficiency to deliver the drug-payload to specified and targeted cancerous cells and tissues. This review undertakes an extensive, across-the-board and all-inclusive approach consisting of various studies encompassing different types of tailored and customized nanoformulations and nanomaterials designed for targeting the transcription factors implicated in the process of carcinogenesis, tumor-maturation, growth and metastasis. Various transcription factors viz. nuclear factor kappa (NF-κB), signal transducer and activators of transcription (STAT), Cmyc and Twist-related protein 1 (TWIST1) along with several types of nanoparticles targeting these transcription factors have been summarized here. A section has also been dedicated to the different types of nanoparticles targeting the hypoxia inducing factors. Efforts have been made to summarize several other transcription factors implicated in various stages of cancer development, growth, progression and invasion, and their targeting with different kinds of nanomedicinal agents.

Transformation pathways and fate of engineered nanoparticles (ENPs) in distinct interactive environmental compartments: A review

The ever increasing production and use of nano-enabled commercial products release the massive amount of engineered nanoparticles (ENPs) in the environment. An increasing number of recent studies have shown the toxic effects of ENPs on different organisms, raising concerns over the nano-pollutants behavior and fate in the various environmental compartments. After the release of ENPs in the environment, ENPs interact with various components of the environment and undergoes dynamic transformation processes. This review focus on ENPs transformations in the various environmental compartments. The transformation processes of ENPs are interrelated to multiple environmental aspects. Physical, chemical and biological processes such as the homo- or hetero-agglomeration, dissolution/sedimentation, adsorption, oxidation, reduction, sulfidation, photochemically and biologically mediated reactions mainly occur in the environment consequently changes the mobility and bioavailability of ENPs. Physico-chemical characteristics of ENPs (particle size, surface area, zeta potential/surface charge, colloidal stability, and core-shell composition) and environmental conditions (pH, ionic strength, organic and inorganic colloids, temperature, etc.) are the most important parameters which regulated the ENPs environmental transformations. Meanwhile, in the environment, organisms encountered multiple transformed ENPs rather than the pristine nanomaterials due to their interactions with various environmental materials and other pollutants. Thus it is the utmost importance to study the behavior of transformed ENPs to understand their environmental fate, bioavailability, and mode of toxicity.

Synthesis of Gold Nanoparticles Using Mimosa tenuiflora Extract, Assessments of Cytotoxicity, Cellular Uptake, and Catalysis

Synthesis of gold nanoparticles (AuNPs) with plant extracts has gained great interest in the field of biomedicine due to its wide variety of health applications. In the present work, AuNPs were synthesized with Mimosa tenuiflora (Mt) bark extract at different metallic precursor concentrations. Mt extract was obtained by mixing the tree bark in ethanol-water. The antioxidant capacity of extract was evaluated using 2,2-diphenyl-1-picrylhydrazyl and total polyphenol assay. AuNPs were characterized by transmission electron microscopy, X-ray diffraction, UV-Vis and Fourier transform infrared spectroscopy, and X-ray photoelectron spectrometry for functional group determination onto their surface. AuMt (colloids formed by AuNPs and molecules of Mt) exhibit multiple shapes with sizes between 20 and 200 nm. AuMt were tested on methylene blue degradation in homogeneous catalysis adding sodium borohydride. The smallest NPs (AuMt1) have a degradation coefficient of 0.008/s and reach 50% degradation in 190s. Cell viability and cytotoxicity were evaluated in human umbilical vein endothelial cells (HUVEC), and a moderate cytotoxic effect at 24 and 48 h was found. However, toxicity does not behave in a dose-dependent manner. Cellular internalization of AuMt on HUVEC cells was analyzed by confocal laser scanning microscopy. For AuMt1, it can be observed that the material is dispersed into the cytoplasm, while in AuMt2, the material is concentrated in the nuclear periphery.